摘要
目的:建立二肽基肽酶4抑制剂LGT-6在不同种属血浆中蛋白结合率的测定方法并比较差异。方法:采用平衡透析法,以磷酸盐缓冲液为透析外液,将3、30、300、3000 nmol/L的LGT-6分别在大鼠、猴、人血浆(即透析内液)中平衡48 h。以甲苯磺丁脲为内标,采用超高效液相色谱-串联质谱法测定透析内、外液中LGT-6的浓度,计算血浆蛋白结合率。以ACQUITY UPLCHSS T3为色谱柱,以水(含0.01%甲酸)-乙腈(含0.01%甲酸)为流动相进行梯度洗脱,流速为0.6 mL/min,柱温为40℃,进样量为2μL;离子源为电喷雾离子源,监测模式为多反应监测模式,采集模式为正离子模式,定量分析用离子对分别为m/z 487.0→434.3(LGT-6)、m/z 271.1→172.0(内标)。结果:在3、30、300、3000 nmol/L浓度下,LGT-6在大鼠血浆中的蛋白结合率分别为(96.25±0.97)%、(84.16±1.24)%、(78.25±0.61)%、(66.63±0.95)%,在猴血浆中的蛋白结合率分别为(98.54±0.58)%、(87.27±1.01)%、(79.35±0.86)%、(66.69±0.54)%,在人血浆中的蛋白结合率分别为(99.40±1.03)%、(84.48±1.15)%、(77.62±0.77)%、(66.93±0.48)%。在相同浓度下,LGT-6在大鼠、猴和人血浆中的蛋白结合率没有明显差异(P>0.05);在相同种属血浆中,不同浓度LGT-6的血浆蛋白结合率组间比较差异有统计学意义(P<0.05),且有随药物浓度的升高而降低的趋势。结论:成功建立了测定LGT-6血浆蛋白结合率的方法。在相同浓度下,LGT-6在大鼠、猴、人血浆中的蛋白结合率没有明显的种属差异,但有明显的浓度依赖趋势。
OBJECTIVE:To establish the method for determining protein binding rate of dipeptidyl peptidase-4 inhibitor LGT-6 in different species of plasma,and to compare their difference.METHODS:By equilibrium dialysis,LGT-6(3,30,300,3000 nmol/L)was equilibrated in rat,monkey and human plasma(i.e.internal dialysis solution)for 48 h,using phosphate buffer as the external dialysis solution.The concentration of LGT-6 in internal and external dialysis solution was determined by UPLC-MS/MS using tolbutamide as internal standard,and the plasma protein binding rate was calculated.The determination was performed on ACQUITY UPLC HSS T3 column with water(containing 0.01%formic acid)-acetonitrile(containing 0.01%formic acid)as mobile phase at the flow rate of 0.6 mL/min.The column temperature was 40℃,and the sample size was 2μL.The ion source was electrospray ion source,and the multiple ion monitoring mode was used to carry out positive ionization scanning.The ion pairs for quantitative analysis were m/z 487.0→434.3(LGT-6),m/z 271.1→172.0(internal standard),respectively.RESULTS:At the concentrations of 3,30,300,and 3000 nmol/L,the protein binding rates of LGT-6 in rat plasma were(96.25±0.97)%,(84.16±1.24)%,(78.25±0.61)%,(66.63±0.95)%;the protein protein binding rates in monkey plasma were(98.54±0.58)%,(87.27±1.01)%,(79.35±0.86)%,(66.69±0.54)%;the protein binding rates in human plasma were(99.40±1.03)%,(84.48±1.15)%,(77.62±0.77)%,(66.93±0.48)%.At the same concentration,the protein binding rates of LGT-6 in rat,monkey and human plasma had no significant difference(P>0.05).In the same species of plasma,there were significant differences in the plasma protein binding rates of different concentration of LGT-6 among those groups(P<0.05),and it decreased with the increase of drug concentration.CONCLUSIONS:The method for the determination of plasma protein binding rate of LGT-6 is successfully established.The data revealed that the protein binding rate of LGT-6 is concentration-dependent,there was no obvious species difference on protein binding rates of LGT-6 in rat,monkey and human plasma under the same concentration.
作者
廖伟科
杨华丽
王忠元
陈瑞
汤磊
崔杏
朱高峰
LIAO Weike;YANG Huali;WANG Zhongyuan;CHEN Rui;TANG Lei;CUI Xing;ZHU Gaofeng(Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D,Guiyang 550004,China;College of Pharmacy,Guizhou Medical University,Guiyang 550004,China;Dept.of Pharmacy,Guizhou Provincial People’s Hospital,Guiyang 550002,China)
出处
《中国药房》
CAS
北大核心
2021年第14期1728-1733,共6页
China Pharmacy
基金
贵州省科技计划项目(No.黔科合支撑〔2019〕2761号)
贵州省高层次创新型人才“百层次人才”项目(No.黔科合平台人才〔2016〕4015)。